Copper-Based Compound Shows Promise in Clearing Alzheimer's Proteins
Study Finds Copper Drug Targets Alzheimer's Protein Clearance
Researchers have developed a copper-based compound that restores the brain's natural ability to clear toxic proteins associated with Alzheimer's disease. In laboratory experiments, the drug dramatically reduced amyloid buildup and improved memory function.
The approach differs from many current Alzheimer's treatments by enhancing the brain's own clearance mechanisms rather than simply targeting amyloid plaques. According to the research team, the compound helps restore cellular processes that become impaired in Alzheimer's disease.
A key advantage of this potential treatment is its existing safety profile. The copper-based drug has already undergone human testing for other neurological conditions, which could accelerate its path through clinical trials for Alzheimer's disease.